Global Self-Testing Market Size study & Forecast, by Product (Diagnostic kits, Diagnostic device, Diagnostic strips), by Sample (Urine, Blood, Stools, Oral Swabs, Other), by Application (Cholesterol and Triglycerides Tests, Diabetes and Glucose Tests, Ovu

Global Self-Testing Market Size study & Forecast, by Product (Diagnostic kits, Diagnostic device, Diagnostic strips), by Sample (Urine, Blood, Stools, Oral Swabs, Other), by Application (Cholesterol and Triglycerides Tests, Diabetes and Glucose Tests, Ovulation Test Cancer Test, Intolerance or Celiac disease Test, Allergy Test, Anemia Test) and Regional Analysis, 2023-2030

Global Self-Testing Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Self-Testing is creating new opportunities for tracking, diagnosing, and addressing in patients treatment and their care. To identify the possible hazards of illnesses, manufacturers are creating testing kits for wellness and preventative measures, spanning from acute infection diagnosis to chronic condition management. As the utilization of opioids for chronic illness treatment continues to increase and the alarming rates of mortality and morbidity linked to their misuse become apparent, pain management approaches within the medical community are undergoing transformation with the integration of substance abuse testing as a crucial aspect. The market growth is driven by key factors such as increasing value-based care and growing demand for unauthorized home COVID kits for testing.

According to Statista, The United States has conducted the most COVID-19 tests globally as of December 22, 2022, with over 1.15 billion tests. There have been more than 273 million tests in Russia. The COVID-19 epidemic has severely taxed health systems all around the world. There was a tremendous demand for test kits at the start of the epidemic, but production capacity was limited. The early outbreak of the disease in the United States was undiscovered for weeks due to defective testing kits made by the Centers for Disease Control and Prevention. However, the rising number of false tests stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Self-Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increased technology advancement and use of home kits. On the other side, Asia Pacific is expected to be the fastest growing region due to its large population and growing awareness about the convenience and acceptability of self-testing kits.

Major market player included in this report are:
Piramal Enterprises Ltd
Quidel Corporation
ARKRAY Inc.
True Diagnostics Inc.
ACON Laboratories Inc.
Assure Tech (Hangzhou) Co. Ltd.
Becton Dickinson & Company
Bionime Corporation
Roche Holding AG
True Diagnostics Inc.

Recent Developments in the Market:
In January 2022, Florida Atlantic University (FAU) granted around USD 1.3 million to NIH for the development of automated, quick HIV self-kits. After a programmatic evaluation of the results of the first phase's progress, another USD 1.3 million would be granted for this endeavour.
In January 2023, The NIH and Administration for Strategic Preparedness and Response (ASPR) collaborated to launch the Home Test to Treat programme. This virtual community health intervention would provide free COVID health services in a few selected communities, including telehealth consultations, home treatments, and at-home rapid tests.

Global Self-Testing Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Sample, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Diagnostic kits
Diagnostic device
Diagnostic strips

By Sample:
Urine
Blood
Stools
Oral Swabs
Other

By Application:
Cholesterol and Triglycerides Tests
Diabetes and Glucose Tests
Ovulation Test Cancer Test
Intolerance or Celiac disease Test
Allergy Test
Anemia Test

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Piramal Enterprises Ltd
Quidel Corporation
ARKRAY Inc.
True Diagnostics Inc.
ACON Laboratories Inc.
Assure Tech (Hangzhou) Co. Ltd.
Becton Dickinson & Company
Bionime Corporation
Roche Holding AG
True Diagnostics Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.